• Sonic Healthcare posted FY2026 revenue of A$10.87 billion, up 13%.
• Statutory net profit climbed 18% to A$608 million; statutory EPS rose 15% to 123.0 Australian cents.
• Underlying net profit increased 17% to A$621 million; underlying EPS rose 14% to 125.6 Australian cents.
• Underlying EBITDA rose 11% to A$1.93 billion; statutory EBITDA increased 9% to A$1.88 billion.
• LADR Laboratory Group acquisition completed; integration progressing with synergy realisation on schedule, dividend lifted 1 cent to A$1.08.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonic Healthcare Limited published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.